ETF MANAGERS GROUP, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$46,581
+79.9%
18,339
+32.4%
0.00%
+100.0%
Q4 2022$25,898
-38.3%
13,849
-14.5%
0.00%0.0%
Q3 2022$42,000
+20.0%
16,190
-5.9%
0.00%0.0%
Q2 2022$35,000
-22.2%
17,212
+13.1%
0.00%0.0%
Q1 2022$45,000
-33.8%
15,224
+0.3%
0.00%0.0%
Q4 2021$68,000
-20.0%
15,173
-11.6%
0.00%
-50.0%
Q3 2021$85,000
-9.6%
17,173
+24.0%
0.00%0.0%
Q2 2021$94,000
-2.1%
13,844
-1.0%
0.00%0.0%
Q1 2021$96,000
-30.4%
13,981
-37.0%
0.00%
-33.3%
Q4 2020$138,000
-1.4%
22,199
-12.7%
0.00%
-25.0%
Q3 2020$140,000
+118.8%
25,434
+102.3%
0.00%
+100.0%
Q2 2020$64,00012,5700.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders